ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $988,000 | +2370.0% | 163,891 | +1371.3% | 0.01% | – |
Q3 2019 | $40,000 | +1233.3% | 11,139 | +969.0% | 0.00% | – |
Q1 2019 | $3,000 | -72.7% | 1,042 | -84.9% | 0.00% | – |
Q4 2018 | $11,000 | -92.0% | 6,887 | -81.7% | 0.00% | -100.0% |
Q3 2018 | $138,000 | +165.4% | 37,598 | +108.2% | 0.00% | – |
Q4 2017 | $52,000 | +108.0% | 18,061 | +231.0% | 0.00% | – |
Q3 2017 | $25,000 | +38.9% | 5,457 | +37.1% | 0.00% | – |
Q2 2017 | $18,000 | -45.5% | 3,981 | -49.2% | 0.00% | – |
Q1 2017 | $33,000 | -89.7% | 7,840 | -89.9% | 0.00% | -100.0% |
Q4 2016 | $320,000 | -34.2% | 77,478 | +29.2% | 0.00% | -40.0% |
Q3 2016 | $486,000 | +36.5% | 59,978 | +31.4% | 0.01% | +25.0% |
Q2 2016 | $356,000 | -39.8% | 45,643 | -40.3% | 0.00% | -50.0% |
Q1 2016 | $591,000 | -70.1% | 76,489 | -58.2% | 0.01% | -65.2% |
Q4 2015 | $1,975,000 | +401.3% | 183,055 | +221.0% | 0.02% | +360.0% |
Q3 2015 | $394,000 | -78.3% | 57,020 | -72.2% | 0.01% | -80.0% |
Q2 2015 | $1,814,000 | -32.0% | 204,746 | -24.4% | 0.02% | -40.5% |
Q1 2015 | $2,669,000 | +104.8% | 270,698 | +154.6% | 0.04% | +110.0% |
Q4 2014 | $1,303,000 | -78.4% | 106,330 | -82.4% | 0.02% | -78.5% |
Q3 2014 | $6,037,000 | +0.7% | 604,906 | -23.7% | 0.09% | +1.1% |
Q2 2014 | $5,998,000 | +297.2% | 792,310 | +72.6% | 0.09% | +268.0% |
Q1 2014 | $1,510,000 | -28.4% | 458,974 | -27.7% | 0.02% | -21.9% |
Q4 2013 | $2,108,000 | -32.2% | 634,972 | +67.0% | 0.03% | -58.4% |
Q2 2013 | $3,111,000 | – | 380,323 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |